Septodont’s Novocol Pharma Division Receives $32.7M Contribution From the Canadian Government to Expand its Injectables Capabilities
The Government of Canada has recently announced major investments in Canadian firms, including a $32.7 million contribution to Septodont’s division in Cambridge, Ontario. This investment will support a significant project to increase Canada’s biomanufacturing capacity for fill-finish of sterile injectables in a state-of-the-art GMP facility expansion. “Such a proud moment for Septodont. By creating such … Read more